| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/11/2011 | US20110195020 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
| 08/11/2011 | US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer |
| 08/11/2011 | US20110195018 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists |
| 08/11/2011 | US20110192493 Liquid Pharmaceutical Formulations of Palonosetron |
| 08/11/2011 | CA2788835A1 The use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with inhibitors of calcineurin or inhibitors of the mammalian target of rapamycin (mtor) complexes |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | CA2788720A1 Medicament for treating and/or preventing cancer |
| 08/11/2011 | CA2788718A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788716A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788715A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788689A1 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof |
| 08/11/2011 | CA2788547A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788545A1 Pharmaceutical composition for treating and/or preventing cancer |
| 08/11/2011 | CA2788071A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
| 08/11/2011 | CA2786927A1 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof |
| 08/11/2011 | CA2786337A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
| 08/10/2011 | EP2354791A1 Immunocytokines with modulated selectivity |
| 08/10/2011 | EP2354160A1 Engineered anti-IL-23-antibodies |
| 08/10/2011 | EP2354152A1 Peptide antagonist of interleukin-15 activity |
| 08/10/2011 | EP2354148A2 Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof |
| 08/10/2011 | EP2354140A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 08/10/2011 | EP2354139A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 08/10/2011 | EP2353611A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 08/10/2011 | EP2353604A1 Pharmaceutical composition and health food comprising rhodiola sachalinensis and oldenlandia diffusa for preventing and treating cancer |
| 08/10/2011 | EP2353603A2 Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng |
| 08/10/2011 | EP2353599A1 8-hydroxyquinolines as inhibitors of cathepsin B |
| 08/10/2011 | EP2352816A1 Human progenitor t-cells |
| 08/10/2011 | EP2352761A2 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 08/10/2011 | EP2352746A1 Bioactive compounds |
| 08/10/2011 | EP2352733A1 Benzonaphtyridine compounds used as inhibitors of autotaxin |
| 08/10/2011 | EP2352526A1 Treating cancer stem cells using targeted cargo proteins |
| 08/10/2011 | EP2352523A1 Improved anti-cd19 antibodies |
| 08/10/2011 | EP2352520A1 Vaccination with poxvirus vectors via mechanical epidermal disruption |
| 08/10/2011 | EP2352508A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 08/10/2011 | EP2352504A2 Treatment of proliferative disorders with a death receptor agonist |
| 08/10/2011 | EP2352501A1 Compounds for the treatment of osteoporosis and cancers |
| 08/10/2011 | EP2352496A1 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms |
| 08/10/2011 | EP2352492A2 Small molecule modulators of epigenetic regulation and their therapeutic applications |
| 08/10/2011 | EP2265580B1 Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 08/10/2011 | EP2197854B1 A new class of histone deacetylase inhibitors |
| 08/10/2011 | EP1841760B1 Pyrimidine derivatives as kinase modulators and method of use |
| 08/10/2011 | EP1830853B1 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 08/10/2011 | EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 08/10/2011 | EP1565581B1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/10/2011 | EP1507554B1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 08/10/2011 | EP1471052B1 Geranyl compounds |
| 08/10/2011 | EP1438388B1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 08/10/2011 | EP1430157B1 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/10/2011 | EP1358206B1 Peptide-based compounds |
| 08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
| 08/10/2011 | EP1135513B2 Adenovirus-mediated gene therapy |
| 08/10/2011 | EP1068296B1 Compositions for eliciting an immune response to a telomerase antigen |
| 08/10/2011 | CN201923970U 一种香菇多糖分离纯化及浓缩装置 One kind of mushroom polysaccharide purification and concentration device |
| 08/10/2011 | CN1990037B Thymosin alpha1 active fragment and polyethylene glycol derivative thereof |
| 08/10/2011 | CN1853627B Cyclodextrin of bibenziisosehenazole ethane or cyclodextrin derivative inclusion compound, and preparation and use thereof |
| 08/10/2011 | CN1817906B Antibody against human parathormone related peptides |
| 08/10/2011 | CN1741821B Compositions for cancer treatment |
| 08/10/2011 | CN1551878B 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 08/10/2011 | CN102149827A Use of MiR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy |
| 08/10/2011 | CN102149820A Cell capable of expressing exogenous GITR ligand |
| 08/10/2011 | CN102149730A FGF-R4 receptor-specific antagonists |
| 08/10/2011 | CN102149714A Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/10/2011 | CN102149713A Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149712A Pyrazole [3, 4-b] pyridine Raf inhibitors |
| 08/10/2011 | CN102149711A Organic compounds |
| 08/10/2011 | CN102149708A Pyrrolidin-2-ones as HDM2 ligands |
| 08/10/2011 | CN102149706A Antineoplastic derivatives of 4-oxo-L,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149703A Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers |
| 08/10/2011 | CN102149689A Substituted 1-benzyl-cinnolin-4(1H)-one derivatives, preparation thereof, and therapeutic use thereof |
| 08/10/2011 | CN102149687A Novel imidazolidine compounds as androgen receptor modulators |
| 08/10/2011 | CN102149678A Novel ortho-aminoanilides for the treatment of cancer |
| 08/10/2011 | CN102149432A Organoarsenic compounds and methods for the treatment of cancer |
| 08/10/2011 | CN102149391A Compositions and methods for treatment of neoplastic disease |
| 08/10/2011 | CN102149388A Novel acetates of 2-deoxy monosaccharides with anticancer activity |
| 08/10/2011 | CN102146454A Use of SLC 19A3 gene |
| 08/10/2011 | CN102146418A Recombinant II type herpes simplex virus vector, preparation method of recombinant II type herpes simplex virus vector, recombinant virus, medicinal composition and application |
| 08/10/2011 | CN102146412A Small molecular non-coding RNA gene hsa-miR-29b and use thereof |
| 08/10/2011 | CN102146142A Method for preparing astragalus polysaccharides |
| 08/10/2011 | CN102146133A Long-acting recombinant interferon and method for constructing, expressing and purifying recombinant expression engineering bacteria thereof |
| 08/10/2011 | CN102146115A 3-substituent-B-Homo-steride-B-cyclolactam compound as well as preparation method and application to preparing antitumor medicaments |
| 08/10/2011 | CN102146108A Synthesis of 3'-triazoepirubicin with anticancer activity |
| 08/10/2011 | CN102146107A Synthesis and anti-tumor activity of (S)-2-hydroxyalkyl-1,4-dihydroxyl-9-10-anthraquinone and glycosyl conjugates |
| 08/10/2011 | CN102146096A Aniline quinazoline compound as well as preparation method and application thereof |
| 08/10/2011 | CN102146095A Pyrrole indolone compounds and preparation method and use thereof |
| 08/10/2011 | CN102146088A Copper complex of phenanthroline derivatives and preparation method and application thereof |
| 08/10/2011 | CN102146084A 3-cyan-6-aminoquinoline derivatives, preparation method thereof and application thereof in medicines |
| 08/10/2011 | CN102146082A Medicinal salts of pyrrolo-nitrogenous heterocyclic derivatives, and preparation method and application thereof to medicines |
| 08/10/2011 | CN102146081A Indoleacetic acid derivatives and preparation method and application thereof |
| 08/10/2011 | CN102146080A Beta-carboline alkali derivative compounds and application thereof |
| 08/10/2011 | CN102146076A Novel anilinoquinazoline derivatives and preparation method thereof |
| 08/10/2011 | CN102146074A Preparation method of pyrrole derivative and application thereof |
| 08/10/2011 | CN102146059A Quinazoline derivatives and preparation method and application thereof |
| 08/10/2011 | CN102146056A N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives |
| 08/10/2011 | CN102146054A Piperlongumine derivatives and medicinal composition and application to preparation of medicament for inhibiting tumor growth thereof |
| 08/10/2011 | CN102146014A Method for extracting squalene by using camellia oleosa seeds as raw materials and tea oil and squalene soft capsules |
| 08/10/2011 | CN102145181A siRNA for inhibiting tumor growth and oligomeric nucleic acid combination and application of siRNA |
| 08/10/2011 | CN102145180A Application of miR-34c in preparation of medicaments or health-care products for treating or preventing liver cancers |
| 08/10/2011 | CN102145178A PEG interleukin 15 |
| 08/10/2011 | CN102145177A Method for preparing folate molecular targeted magnetic nanometer medicine carrier and targeting gene medicine |
| 08/10/2011 | CN102145176A Targeting protein-polyethylene glycol-anticancer medicament junctional complex |